logo
Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032

Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032

Business Upturn11-06-2025
By GlobeNewswire Published on June 11, 2025, 22:00 IST
New York, USA, June 11, 2025 (GLOBE NEWSWIRE) — Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight
The electronic health records market is experiencing robust growth, primarily driven by the increasing incidence of chronic diseases that require ongoing monitoring, data management, and coordinated long-term care. This rising demand has led to a greater need for integrated healthcare systems capable of seamlessly sharing patient information across departments and care settings. In response, governments worldwide are introducing supportive policies, funding programs, and regulatory frameworks to boost EHR adoption and improve healthcare efficiency. At the same time, major industry players are ramping up innovation, launching advanced, user-friendly, and interoperable EHR solutions that leverage artificial intelligence and data analytics.
DelveInsight's Electronic Health Record Market Insights report provides the current and forecast market analysis, individual leading electronic health record companies' market shares, challenges, electronic health record market drivers, barriers, trends, and key market electronic health record companies in the market.
Key Takeaways from the Electronic Health Record Market Report As per DelveInsight estimates, North America is anticipated to dominate the global electronic health record market during the forecast period.
In the product & services segment of the electronic health record market, the software category captured a significant revenue share in 2024.
Notable electronic health record companies such as Epic Systems Corporation, Oracle, Veradigm LLC, Medical Information Technology, Inc., athenahealth, NXGN Management, LLC, eClinicalWorks, Greenway Health, LLC, Practice Fusion, Inc., Particle Health, Practice Fusion, Inc., American Well, Medisafe, GetWellNetwork, Inc., Personify Health, Luma Health Inc., CipherHealth Inc., Relatient, CureMD Healthcare, Oneview Healthcare, and several others are currently operating in the electronic health record market.
and several others are currently operating in the electronic health record market. In April 2025, Wolters Kluwer Health announced an expanded integration with the EHR company Epic, enabling UpToDate Enterprise customers and their patients to access patient education content directly within the Epic EHR and MyChart patient portal.
announced an expanded integration with the EHR company Epic, enabling UpToDate Enterprise customers and their patients to access patient education content directly within the Epic EHR and MyChart patient portal. In November 2024, Suki , a leader in AI technology for healthcare, announced partnerships with EHR providers MEDENT and Azalea Health. Both companies integrated Suki's AI engine, the Suki Platform, into their systems to enhance user experience and improve patient care.
, a leader in AI technology for healthcare, announced partnerships with EHR providers MEDENT and Azalea Health. Both companies integrated Suki's AI engine, the Suki Platform, into their systems to enhance user experience and improve patient care. In May 2024, Athenahealth announced the launch of athenaOne for Women's Health and athenaOne for Urgent Care.
To read more about how do electronic health records improve workflow processes, get a snapshot of the key highlights entailed in the Functions of Electronic Health Records
Electronic Health Record Overview
An electronic health record (EHR) is a digital version of a patient's paper chart and is designed to be accessed by authorized users across different healthcare settings. It contains comprehensive health information such as medical history, diagnoses, medications, immunization dates, allergies, lab results, and physician notes. Unlike traditional paper records, EHRs allow real-time, secure access to patient data, thereby improving coordination among healthcare providers, reducing errors, and facilitating more accurate diagnoses and treatment.
EHR systems also support better patient engagement and healthcare analytics. Patients can access their own health records through secure portals, empowering them to participate in their care. Meanwhile, healthcare providers can use EHR data for population health management, tracking outcomes, and improving efficiency. Despite these benefits, EHR implementation can face challenges such as high costs, interoperability issues between systems, and data privacy concerns. Nonetheless, EHRs are central to modern healthcare infrastructure and play a crucial role in advancing quality, safety, and patient-centered care.
Electronic Health Record Market Insights
North America led the electronic health record market in 2024, holding the largest market share. This leadership is primarily due to the rising incidence of chronic illnesses, largely stemming from an aging population. The region is also witnessing increased adoption of telehealth services and a growing emphasis on patient-centric care, both of which are driving market expansion. Moreover, advancements in technology and robust governmental support for digital health initiatives are significantly contributing to the growth of the EHR market in North America.
EHRs are essential in chronic disease management, enabling consistent, coordinated, and data-informed care. They help healthcare providers monitor patient conditions over time, track medication adherence, and detect health trends through real-time access to medical records, lab results, and treatment plans. Additionally, EHR systems support preventive care by issuing alerts for screenings, follow-up visits, and routine health checks, which helps reduce complications, hospital admissions, and emergency room visits, especially for patients with chronic conditions like diabetes, hypertension, and cardiovascular disease.
Leading companies in the region are also focusing on innovation to enhance their EHR offerings and strengthen their market presence. For instance, in May 2024, Athenahealth introduced athenaOne for Women's Health and athenaOne for Urgent Care, cloud-based, integrated solutions that combine EHR capabilities with practice management, revenue cycle tools, and patient engagement features. These tailored platforms aim to meet the unique needs of various medical specialties.
To know more about why the North America electronic health record (EHR) market is leading, get a snapshot of the Electronic Health Record Development
Electronic Health Records Market Dynamics
The electronic health record market is undergoing rapid transformation, driven by the convergence of technological advancements, healthcare digitization mandates, and growing demand for data interoperability. Governments around the world, especially in developed economies, are investing in digital healthcare infrastructure, with policies aimed at improving healthcare efficiency and patient outcomes. For instance, initiatives like the U.S. HITECH Act and the European Union's digital health strategies have accelerated EHR adoption among providers. As a result, hospitals, clinics, and physician practices are increasingly moving toward integrated EHR systems that can facilitate seamless access to patient data across various touchpoints.
A key dynamic shaping the EHR market is the growing need for interoperability and patient data portability. Historically, many EHR systems operated in silos, leading to fragmented patient records and care delays. Today, both regulators and healthcare providers are pushing for open APIs, FHIR standards, and cross-platform compatibility. This trend is fostering innovation among EHR vendors who now need to balance robust functionality with open architecture. Companies like Epic, Cerner (now part of Oracle), and athenahealth are continuously evolving their platforms to remain competitive in a market where connectivity and integration have become key differentiators.
Cloud adoption is another significant driver, as cloud-based EHR systems offer scalability, lower upfront infrastructure costs, and easier access for remote care. The rise of telemedicine and virtual care, accelerated by the COVID-19 pandemic, has underscored the need for accessible, real-time patient information. This has led smaller practices and large healthcare systems alike to transition from on-premise to SaaS-based EHR models. However, this shift also raises concerns around data security and compliance, particularly with HIPAA in the U.S. and GDPR in the EU, compelling vendors to invest in advanced cybersecurity features.
Despite these advancements, the EHR market continues to face challenges such as user dissatisfaction, high implementation costs, and workflow inefficiencies. Physicians often report that EHRs can be cumbersome, leading to increased administrative burdens. To counter this, there's growing interest in AI-driven tools and natural language processing (NLP) that can automate documentation, improve decision support, and enhance user experience. Vendors that prioritize user-centric design and clinical efficiency are likely to gain a competitive edge.
Overall, the EHR market is expected to grow steadily, but its trajectory will depend on how well stakeholders—vendors, providers, regulators—collaborate to address longstanding issues of usability, standardization, and data security. As healthcare continues to evolve into a more data-driven, value-based model, EHR systems will remain central to enabling coordinated care, population health management, and patient engagement.
Get a sneak peek of the benefits of using electronic health records @ Advantages and Disadvantages of Electronic Health Records Report Metrics Details Coverage Global Study Period 2022–2032 Electronic Health Records Market CAGR ~6% Electronic Health Records Market Size by 2032 USD 53.5 Billion Key Electronic Health Record Companies Epic Systems Corporation, Oracle, Veradigm LLC, Medical Information Technology, Inc., athenahealth, NXGN Management, LLC, eClinicalWorks, Greenway Health, LLC, Practice Fusion, Inc., Particle Health, Practice Fusion, Inc., American Well, Medisafe, GetWellNetwork, Inc., Personify Health, Luma Health Inc., CipherHealth Inc., Relatient, CureMD Healthcare, Oneview Healthcare, among others
Electronic Health Records Market Assessment Electronic Health Records Market Segmentation Electronic Health Records Market Segmentation By Product and Services: Hardware, Software, and Services Electronic Health Records Market Segmentation By Deployment: On-premise, Cloud, and Hybrid Electronic Health Records Market Segmentation By Application: Clinical Decision Making, Administrative Support, Patient Management, and Others Electronic Health Records Market Segmentation By End Users: Hospitals & Clinics, Ambulatory Surgical Centers, and Others Electronic Health Records Market Segmentation By Geography : North America, Europe, Asia-Pacific, and Rest of World
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the electronic health records market are set to emerge as the trendsetter explore @ Electronic Health Record Companies
Table of Contents 1 Electronic Health Record Market Report Introduction 2 Electronic Health Record Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Electronic Health Record Market Key Factors Analysis 6 Electronic Health Record Market Porter's Five Forces Analysis 7 Electronic Health Record Market Layout 8 Electronic Health Record Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us
Interested in knowing how does electronic health records improve patient care? Click to get a snapshot of the Benefits of Electronic Health Records
Related Reports
Chronic Heart Failure Market
Chronic Heart Failure Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key CHF companies, including Cytokinetics, Bayer, Eli Lilly, BioCardia, Mesoblast, Tenax Therapeutics, Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Intra-Cellular Therapies, Cardurion Pharmaceuticals, Rivus Pharmaceuticals, among others.
Acute Coronary Syndrome Market
Acute Coronary Syndrome Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key ACS companies, including Novartis, Boehringer Idorsia Pharmaceuticals, Viatris, Recardio, AstraZeneca, Faraday Pharmaceuticals, DalCor Pharmaceuticals, Roche, Jiangsu Vcare PharmaTech, CeleCor Therapeutics, Novo Nordisk, Bristol Myers Squibb, Johnson & Johnson Innovative Medicine, CellProthera, BioCardia, Kancera, Amgen, Arrowhead Pharmaceuticals, Abcentra, among others.
Diabetes Market
Diabetes Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key diabetes companies, including Enthera, Nano Precision Medical, Oramed, Dompe Farmaceutici, Carmot Therapeutics, Scohia Pharma, Genexine, REMD Biotherapeutics, among others.
Type 1 Diabetes Market
Type 1 Diabetes Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 1 diabetes companies, including Histogen, Novo Nordisk, Prevention Bio, among others.
Type 2 Diabetes Market
Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 2 diabetes companies, including Sanofi, Eli Lilly and Company, AstraZeneca, Novartis, among others.
DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Pipeline Assessment
Healthcare Licensing Services
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ATN Announces Updated Start Time for Second Quarter 2025 Financial Results Conference Call on August 8, 2025
ATN Announces Updated Start Time for Second Quarter 2025 Financial Results Conference Call on August 8, 2025

Hamilton Spectator

time12 minutes ago

  • Hamilton Spectator

ATN Announces Updated Start Time for Second Quarter 2025 Financial Results Conference Call on August 8, 2025

BEVERLY, Mass., July 29, 2025 (GLOBE NEWSWIRE) — ATN International, Inc. ('ATN' or the 'Company') (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, announced today a change to the start time of its upcoming second quarter 2025 financial results conference call. The call will now begin at 9:00 (ET) on Friday, August 8, 2025, one hour earlier than previously scheduled. All other details remain unchanged. Key details regarding the call are as follows: Call Date: Friday, August 8, 2025 Call Time: 9:00 a.m. ET Webcast Link: Live Call Participant Link: Webcast Link Instructions You can listen to a live audio webcast of the conference call by visiting the 'Webcast Link' above or the 'Events & Presentations' section of the Company's Investor Relations website at . A replay of the conference call will be available at the same locations beginning at approximately 1:00 pm ET on the same day. The Company also will provide an investor presentation as a supplement to the call on the 'Events & Presentations' section of its Investor Relations website. Live Call Participant Instructions To participate in the live call, you must register using the 'Live Call Participant Link' above. Once registered, you will receive dial-in numbers and a unique PIN number. When you dial in, you will input your PIN and be routed into the call. If you register and forget your PIN, or lose the registration confirmation email, simply re-register to receive a new PIN. About ATN ATN International, Inc. (Nasdaq: ATNI), headquartered in Beverly, Massachusetts, is a leading provider of digital infrastructure and communications services for all. The Company operates in the United States and internationally, including the Caribbean region, with a focus on rural and remote markets with a growing demand for infrastructure investments. The Company's operating subsidiaries today primarily provide: (i) advanced wireless and wireline connectivity to residential, business, and government customers, including a range of high-speed Internet and data services, fixed and mobile wireless solutions, and video and voice services; and (ii) carrier and enterprise communications services, such as terrestrial and submarine fiber optic transport, and communications tower facilities. For more information, please visit . Contact: Michele Satrowsky Corporate Treasurer ATN International Inc. IR@ Adam Rogers Investor Relations ATNI@

Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor
Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor

Yahoo

time30 minutes ago

  • Yahoo

Generational Group Advises The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy in its Sale to an Individual Investor

DALLAS, July 29, 2025--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy to an Individual Investor. The acquisition closed June 27, 2025. Based in Rockwall, Texas, The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy offers comprehensive physical, occupational, and speech therapy for children from birth up to seventeen years old. Founded and operated by experienced physical therapists with over 40 years of combined expertise, the clinic treats a range of neurological, orthopedic, and developmental conditions—such as sensory processing disorders, autism, ADHD, cerebral palsy, and feeding issues—using both innovative and traditional tools. With a highly trained staff and a state-of-the-art facility, Excel Pediatric Therapy is committed to intensive treatment, caregiver education, and creating enjoyable therapy environments that promote sustainable progress. Whether families are seeking early intervention or long-term support, Excel Pediatric Therapy works to "make a difference…one child at a time." Generational Group Executive Managing Director, M&A, Central Region – Michael Goss, and his team led by Vice President, M&A, Jacob Mangalath successfully closed the deal. Senior Managing Director, Doug Morrow and Senior M&A Advisor, Mike Moore, established the initial relationship with The Rockwall Center of Sensory Integration, Inc. dba Excel Pediatric Therapy. Ryan Binkley, CEO of Generational Group, stated, "We're committed to delivering results that generate long-term value for all stakeholders. This milestone reflects the effectiveness of our strategy and the trust our clients consistently place in us." About Generational Group Generational Group, headquartered in Dallas, TX, is a leading, award winning full-service M&A advisory firm. Generational has over 300 professionals across 16 offices in North America. The firm empowers business owners to unlock the full value of their companies through a comprehensive suite of services—including strategic growth consulting, exit planning education, business valuation, value enhancement strategies, M&A advisory, digital solutions, and wealth management. Celebrating its 20th year, Generational has successfully closed over 1,700 transactions and has ranked #1 or #2 in all LSEG league tables for deals valued between $25 million and $1 billion in 2022, 2023, and 2024. The firm was named 2024 USA Investment Banking Firm of the Year by the Global M&A Network and recognized as Investment Banking Firm of the Year by The M&A Advisor in both 2024 and 2022. View source version on Contacts Media Contact:Catherine Binkley469-828-2798cbinkley@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Amazon (AMZN) Price Target Raised to $271 — Here's What's Driving It
Amazon (AMZN) Price Target Raised to $271 — Here's What's Driving It

Yahoo

timean hour ago

  • Yahoo

Amazon (AMZN) Price Target Raised to $271 — Here's What's Driving It

Inc. (NASDAQ:AMZN) is one of the . On July 28, UBS analyst Stephen Ju raised the price target on the stock to $271.00 (from $249.00) while maintaining a Buy rating. The price target increase reflects UBS's decision to roll back some of the decreases in estimates it had made three months ago when it was expecting increased demand destruction from tariffs. The firm has raised its Gross Merchandise Value (GMV) estimates for 2026 by an estimated 2%, along with a 2% increase in gross profit projections. Moreover, it has also raised its 2026 and 2027 advertising segment forecasts by an estimated 3% due to better-than-expected advertising performance. Meanwhile, AWS growth estimates were maintained at 16% for the second quarter of 2025. 25 best things to buy on Amazon under $20 (Photo credit: Pixabay) Based on the revisions, there is a 1% increase in 2026 revenue estimates and a 5% increase in EBIT (Earnings Before Interest and Taxes) projections. For the year 2027, the firm projects a 0.1% revenue increase and a 7% EBIT increase. The firm also raised its 2025 CapEx forecast to $112 billion from the previous $107 billion after the company disclosed its first-quarter 2025 capital expenditures. Inc. (NASDAQ:AMZN) is an American technology company offering e-commerce, cloud computing, and other services, including digital streaming and artificial intelligence solutions. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store